Press release
US Transdermal Patch Market Outlook 2020 Report
* US Transdermal Patch Market Overview
* Generic & Branded Transdermal Patches
* US Transdermal Patch Market: Value Chain Analysis
* US Transdermal Patch Contract Manufacturing Organization
* US Transdermal Patch Clinical Pipeline Insight by Company, Indication & Phase
* US Transdermal Patch Clinical Pipeline: 55 Patches
* Majority Patches in Preclinical Phase: 23 Patches
* Marketed Transdermal Patch Clinical Insight by Company & Indication
Download Report Sample Weblink:
https://www.kuickresearch.com/report-US-Transdermal-Patch-Market-Outlook-2020.php
For Report Sample Contact: neeraj@kuickresearch.com
Table of Contents
1. Introduction to Transdermal Patch
2. Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch
3. Why There Exist Need for Transdermal Patches?
4. Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of Transdermal Patch
4.3 Mechanism of Motion Sickness, Nicotine & Female Contraceptive Transdermal Patch
5. Transdermal Patch v/s Traditional Drug Delivery Methods
6. US Transdermal Patch Market Overview
6.1 Current Market Scenario
6.2 US Transdermal Patch Clinical Pipeline Overview
7. Generic & Branded Transdermal Patches
8. Value Chain Analysis for Transdermal Patch Market
8.1 Research & Development
8.2 Manufacturing
8.3 Marketing & Distribution
8.4 Price to End User
9. US Transdermal Patch Contract Manufacturing Organization (CMO)
10. US Transdermal Patch Market Opportunity Assessment
10.1 Parkinson’s Disease
10.2 Alzheimer's Disease
10.3 Female Contraceptive
10.4 Nicotine Replacement Therapy
10.5 Insulin
10.6 Vaccine
11. US Transdermal Patch Market Dynamics
11.1 Favorable Market Parameters
11.2 Commercialization Challenges
12. US Transdermal Patch Market Future Prospects
13. US Transdermal Patch Clinical Pipeline by Company, Indication & Phase
13.1 Research
13.2 Preclinical
13.3 Phase-I
13.4 Phase-I/II
13.5 Phase-II
13.6 Phase-II/III
13.7 Phase-III
13.8 Preregistration
13.9 Registered
14. Marketed Transdermal Patch Clinical Insight by Company & Indication
15. Discontinued & No Development Reported in US Transdermal Patch Clinical Pipeline
15.1 No Development Reported
15.2 Discontinued
15.3 Marketed Withdrawal
16. Competitive Landscape
16.1 3M Pharmaceuticals
16.2 Acrux
16.3 Agile Therapeutics
16.4 Allergan
16.5 ANI Pharmaceuticals
16.6 Antares Pharma
16.7 Bayer HealthCare Pharmaceuticals
16.8 Corium International
16.9 Chase Pharmaceuticals
16.10 DURECT Corporation
16.11 Endo Pharmaceuticals
16.12 Fempharm
16.13 Hisamitsu Pharmaceutical
16.14 Immune Pharmaceuticals
16.15 Imprimis Pharmaceuticals
16.16 Ipsen Bioscience
16.17 Johnson & Johnson
16.18 LaSalle Laboratories
16.19 Lavipharm-increase
16.20 MINRAD International
16.21 NeurogesX
16.22 Noven Pharmaceuticals
16.23 NuPathe
16.24 Nuvo Research
16.25 Novartis
16.26 Pain Therapeutics
16.27 ProStrakan
16.28 Purdue Pharma
16.29 Sanofi
16.30 Scilex Pharmaceuticals
16.31 Senju Pharmaceutical
16.32 Somerset Pharmaceuticals
16.33 Teikoku Seiyaku
16.34 Therapeutic Discovery Corporation
16.35 Transdermal Delivery Solutions Corp
16.36 UCB
16.37 Xel Pharmaceuticals
16.38 Zosano Pharma
Figure 1-1: Steps Involved in Transdermal Permeation
Figure 1-2: Ideal Properties of Transdermal Patch
Figure 2-1: Types of Commercially Available Transdermal Patch
Figure 4-1: Properties of Transdermal Therapeutics
Figure 4-2: Components of Transdermal Patch
Figure 4-3: Types of Permeation Enhancers
Figure 4-4: Schematic Representation of Iontophoresis
Figure 4-5: Mechanism of Scopolamine Transdermal Patch
Figure 4-6: Mechanism of Nicotine Transdermal Patch
Figure 4-7: Mechanism of Female Contraceptive Transdermal Patch
Figure 5-1: Issues with Traditional Drug Delivery Methods
Figure 5-2: Advantages of Transdermal Patch
Figure 5-3: Consistent Drug Supply by Transdermal Patch
Figure 6-1: Advantages of Transdermal Patches
Figure 6-2: Disadvantages of Transdermal Patches
Figure 6-3: US - Major Reasons Behind Growth of Transdermal Patches
Figure 6-4: US - Estimated Prescription Drug Spending (USD Billion), 2015-2020
Figure 6-5: US- Transdermal Drug Delivery System Market (US$ Billion), 2015-2020
Figure 6-6: US - Estimated Prescription Transdermal Patch Market by Volume (%), 2015 & 2020
Figure 6-7: US - Estimated Market Size of Prescription vs. Over-The-Counter Transdermal Patches (US$ Billion), 2015
Figure 6-8: US - Estimated Market Size of Prescription vs. Over-The-Counter Transdermal Patches (US$ Billion), 2020
Figure 6-9: US Transdermal Patch Pipeline by Phase (%), 2016
Figure 6-10: US Transdermal Patch Pipeline by Phase (Numbers), 2016
Figure 6-11: US Transdermal Patch Pipeline by Phase (%), 2016
Figure 6-12: US Transdermal Patch Pipeline by Phase (Numbers), 2016
Figure 7-1: Requirement in Generic Transdermal Patches
Figure 7-2: Reservations for Generic Transdermal Patches
Figure 7-3: US - Estimated Cost Comparison of Branded vs. Generic Contraceptive Patch
Figure 7-4: US - Estimated Cost Comparison of Cigarettes, Generic & Branded Nicotine Patches
Figure 8-1: Basic Features of Transdermal Patch Value Chain
Figure 8-2: Steps Involved in Transdermal Patch Manufacturing
Figure 9-1: Stages of Transdermal Patch Development
Figure 9-2: Advantages of Using Contract Manufacturing Organization for Transdermal Drug Delivery System
Figure 9-3: Requirements from Contract Manufacturing Organization for Transdermal Drug Delivery System
Figure 10-1: Potential Market Segments of Transdermal Drug Delivery Systems
Figure 10-2: US - Susceptibility of Parkinson Disease among Males and Females
Figure 10-3: US - Estimated Increase in Parkinson’s Disease Incidences
Figure 10-4: US - Estimated Financial Impact of Parkinson’s Disease on Economy (US$ Billion)
Figure 10-5: US - Parkinson’s Disease Incidences, 2015-2020
Figure 10-6: US - Estimated Sales of Neupro Patch, 2104-2020
Figure 10-7: US - Estimated Worldwide Sales of Neupro, 2014 & 2015
Figure 10-8: US - Male & Female Suffering from Alzheimer’s Disease (Million), 2015
Figure 10-9: US - Shares of Male & Female Suffering from Alzheimer’s Disease (%), 2015
Figure 10-10: US - Percentage of Elderly People Suffering from Alzheimer’s Disease, 2015
Figure 10-11: US - Estimated Increase in Alzheimer’s Incidences, 2015, 2025 & 2050
Figure 10-12: US - Estimated Incidences of Alzheimer’s Disease, 2015-2020
Figure 10-13: US - Exelon Patch Sales for Alzheimer s Disease, 2013 & 2014
Figure 10-14: Requirements of Female Contraceptive Transdermal Drug Delivery Systems
Figure 10-15: Benefits of Female Contraceptive Transdermal Drug Delivery System
Figure 10-16: US - Expected Revenues Generated by Xulane Patch (US$ Million), 2015-2020
Figure 10-17: US - Decrease in Number of Smokers due to Nicotine Patch, 2005 & 2013
Figure 10-18: Factors Responsible for Increased Consumption of Nicotine Patches
Figure 10-19: Rank of US among Different Diabetes Prone Countries
Figure 10-20: US - Estimated Increase in Diabetes Incidences, 2015-2020
Figure 10-21: Benefits of Insulin Transdermal Patch
Figure 10-22: Drawback of Insulin Transdermal Patch
Figure 10-23: Benefits of Vaccine Transdermal Patch
Figure 10-24: Drawbacks of Vaccine Transdermal Patch
Figure 10-25: US - Estimated HIV Incidences, 2015-2020
Figure 11-1: Transdermal Patch Market Favorable Factors
Figure 11-2: Transdermal Patch Market Commercialization Challenges
Figure 16-1: Acrux Clinical Pipeline
Figure 16-2: Agile Therapeutics Clinical Pipeline
Figure 16-3: Antares Pharma Clinical Pipeline
Figure 16-4: Corium International Clinical Pipeline
Figure 16-5: Durect Corporation Clinical Pipeline
Figure 16-6: Endo Pharmaceuticals Clinical Pipeline
Figure 16-7: Immune Pharmaceuticals Clinical Pipeline
Figure 16-8: Novartis Clinical Pipeline
Figure 16-9: Senju Pharmaceuticals Clinical Pipeline
Figure 16-10: Xel Pharamaceuticals Clinical Pipeline
Figure 16-11: Zosano Pharma Clinical Pipeline
Table 4-1: Transdermal Patches for Various Disease Indications
Table 6-1: Features Required in Transdermal Patches
Table 6-2: US - Different Transdermal Drug Delivery Systems Available in Market
Table 7-1: Similarities & Difference Between Generic & Branded Transdermal Patches
Table 7-2: US - Some Generic Transdermal Patches Available in Market
Table 8-1: Breakdown of Transdermal Patch Value Chain Analysis
Table 10-1: US - Estimated Adoption Rates for Parkinson s Disease Transdermal Patches , 2015-2020
Table 10-2: Description of Neupro Patch for Parkinson’s Disease
Table 10-3: US - Estimated Adoption Rates for Transdermal Drug Delivery Systems for Alzheimer s Disease, 2015-2020
Table 10-4: Transdermal Patches for Alzheimer’s Disease
Table 10-5: Description of Ortho Evra Contraceptive Patch
Table 10-6: Difference Between Generic & Branded Transdermal Contraceptive Products
Table 10-7: US-Estimated Adoption Rates for Transdermal Drug Delivery Systems for Diabetes Mellitus, 2015-2020
Table 10-8: US-Estimated Adoption rates for Transdermal Drug Delivery Systems for HIV, 2015-2020
Table 16-1: Pain Therapeutics Clinical Pipeline
Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.
Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Transdermal Patch Market Outlook 2020 Report here
News-ID: 1040859 • Views: 318
More Releases from Kuick Resarch
Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …
"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research"
"Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights:
• Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs
• Marketed Cancer Antibody Drug Conjugate: 9 Drugs
• Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026
• Majority of Drug Trials Are For Second Line Therapy…
Global Cell Therapy Market Stem Cell Therapy Market Size Sales Growth Clinical T …
Global Cell Therapy Market Size Sales Opportunity To Surpass USD 40 Billion By 2027 Says Kuick Research Report Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027
"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights:
• Global Cell Therapy Market: > USD 40 Billion By 2027
• Cell Therapy Clinical Trial Insight by Indication, Company and Country
• Cell Therapy Price & Product Insight By Region/Country
• Clinical…
Global Small Molecule Targeted Cancer Drug Market Size Sales To Reach US$ 130 Bi …
"Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights:
• Global Small Molecule Cancer Drug Market: > US$ 125 Billion by 2026
• USA Dominates Global Small Molecule Cancer Drug Market: >50% Share
• Number of Small Molecule Cancer Drugs In Clinical Trials: >2500 Drugs
• Small Molecule Cancer Drugs Dosage, Sales, Price & Patent Insight: 175 Drugs
• Small Molecule Drug Insight by Cancer
• Clinical Trials Insight…
GCC Clinical Trial Market Outlook Insight 2025
"GCC Clinical Trial Market Outlook 2025" Report Highlights:
• GCC Clinical Trial Market Opportunity: >US$ 500 Million
• GCC Disease Prevalence & Statistics
• Saudi Arabia Dominating GCC Clinical Trial Landscape: > 500 Trials
• Clinical Trials for Cancer in GCC: > 120 Trials
• Guidelines For Conducting Clinical Trials by Country
• Ongoing Clinical Trials Insight by Country
Download Report: https://www.kuickresearch.com/report-report-report-report-report-report-report-report-gcc-clinical-trial-market-size-number--data-regulation-registration
Table of Contents
1. GCC Clinical Market Regional Insights
2. GCC Clinical Trial Market Dynamics
2.1 Driving Forces for GCC Clinical Trial…
More Releases for Transdermal
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018…
Therapeutic Landscape of Transdermal Drug Delivery Pipeline
Summary
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3090629-transdermal-drug-delivery-medical-devices-pipeline-assessment-2018
Scope
-…
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the…
Global Transdermal Absorption Patch Market Research Report
Latest industry research report on: Global Transdermal Absorption Patch Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Transdermal Absorption Patch industry.
Complete Report Details @ https://www.marketresearchreports.biz/reports/1324598/global-transdermal-absorption-patch-detailed-analysis-report-2017-2022-market-research-reports
This report splits…
Transdermal Drug Delivery System Market 2017 -
Apex Research, recently published a detailed market research study focused on the "Transdermal Drug Delivery System Market" across the global, regional and country level. The report provides 360° analysis of "Transdermal Drug Delivery System Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Transdermal Drug Delivery System industry, and estimates the future…
US Transdermal Patch Market US Transdermal Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Transdermal Patch
2. Classification of Transdermal Patches
2.1 Single/ Multiple-Layer Drug-in-Adhesive
2.2 Reservoir Transdermal Patches
2.3 Matrix Based Transdermal Patches
2.4 Vapor Patch
2.5 Active and Passive Patch
3. Why There Exist Need for Transdermal Patches?
4. Mechanism of Transdermal Patch Drug Delivery
4.1 Properties of Transdermal Therapeutics
4.2 Components of…